Company intelligence / Profile preview
Opocrin SpA
- Ownership
- Private
- Development stage
- Commercial
Overview
Opocrin is a world leader in the production of heparin derivatives and active pharmaceutical ingredients. Their products include sodium heparin, calcium heparin, sulodexide, iron sucrose, and other pharmaceutical ingredients.
- Therapeutic areas
- CardiovascularHematology
- Modalities
- Biological and chemical active pharmaceutical ingredientsheparin derivatives
- Industry
- Biotech
Drug pipeline
1 assetPartnerships
Beyond the preview
Go deeper on Opocrin SpA.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Opocrin SpA.